S Michele Owen Selected Research

S Michele Owen Research Topics

22	Infections 10/2021 - 10/2002
11	HIV Infections (HIV Infection) 01/2020 - 09/2009
3	Acquired Immunodeficiency Syndrome (AIDS) 11/2014 - 02/2012
2	Viremia 01/2020 - 12/2014
1	Vaccine-Preventable Diseases 01/2022
1	COVID-19 01/2022
1	Malaria 01/2022
1	Hepatitis 01/2018
1	Communicable Diseases (Infectious Diseases) 01/2018
1	AIDS-Related Complex (ARC) 01/2017
1	Zika Virus Infection 01/2017
1	Congenital Abnormalities (Deformity) 01/2017
1	Disease Progression 11/2014
1	Persistent Infection 12/2012

7	AntigensIBA 01/2022 - 09/2009
6	Nucleic AcidsIBA 01/2020 - 06/2009
3	AntibodiesIBA 10/2021 - 12/2011
3	Immunoglobulin G (IgG)IBA 01/2020 - 11/2014
2	VaccinesIBA 10/2021 - 10/2002
2	Biomarkers (Surrogate Marker)IBA 01/2016 - 01/2014
2	HIV AntibodiesIBA 12/2013 - 12/2011
2	A-Form DNA (A-DNA)IBA 12/2011 - 10/2002
2	RNA (Ribonucleic Acid)IBA 12/2011 - 12/2011
1	Nucleocapsid ProteinsIBA 01/2022
1	N 30IBA 01/2022
1	Proteins (Proteins, Gene)FDA Link 01/2022
1	APTIBA 01/2020
1	GP 140IBA 01/2019
1	Peptide Hydrolases (Proteases)FDA Link 01/2018
1	IntegrasesIBA 01/2018
1	Opiate AlkaloidsIBA 11/2017
1	Explosive Agents (Explosives)IBA 11/2017
1	Immunoglobulin M (IgM)IBA 01/2017
1	cyclo(Arg-Pro) (CI 4)IBA 01/2017
1	Oxymorphone (Numorphan)FDA LinkGeneric 07/2016
1	N-acetyltalosaminuronic acid (NAT)IBA 04/2015
1	HIV Reverse TranscriptaseIBA 12/2014
1	RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA 12/2014
1	HIV Core Protein p24IBA 12/2013
1	CI 22IBA 12/2012
1	EnzymesIBA 09/2009
1	AIDS VaccinesIBA 10/2002

2	Art Therapy 01/2020 - 02/2012
2	Therapeutics 01/2017 - 01/2017
1	Time-to-Treatment 01/2017
1	Highly Active Antiretroviral Therapy (HAART) 12/2012